Several studies have suggested that certain LRGs are associated with the development and prognosis of ccRCC, including VEGF-C, vascular endothelial growth factor D (VEGF-D), and lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1) 19-21. This evidence concerns the gene LYVE1 and nonpapillary renal cell carcinoma.